Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-30 @ 7:51 AM
Study NCT ID:
NCT00875160
Status:
TERMINATED
Last Update Posted:
2010-08-19
First Post:
2009-04-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study in Type 1 Gaucher Patients to Evaluate the Pharmacokinetics, Safety and Pharmacodynamics of AT2101
Sponsor:
Amicus Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GAU-CL-104
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Eugene Schneider, MD, Medical Director, Clinical Research
Old Organization:
Amicus Therapeutics